<SEC-DOCUMENT>0000920465-20-000057-index.html : 20200504
<SEC-HEADER>0000920465-20-000057.hdr.sgml : 20200504
<ACCEPTANCE-DATETIME>20200501202304
ACCESSION NUMBER:		0000920465-20-000057
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20200504
DATE AS OF CHANGE:		20200501
EFFECTIVENESS DATE:		20200504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LA JOLLA PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000920465
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330361285
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36282
		FILM NUMBER:		20842408

	BUSINESS ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-207-4264

	MAIL ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>proxy2020defa14avirtualmee.htm
<DESCRIPTION>DEFA14A
<TEXT>
Document 1 - file: proxy2020defa14avirtualmee.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lajolla2019proxy01page1.jpg
<TEXT>
Document 2 - file: lajolla2019proxy01page1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lajolla2019proxy01page2.jpg
<TEXT>
Document 3 - file: lajolla2019proxy01page2.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>lajolla2019proxy01page3.jpg
<TEXT>
Document 4 - file: lajolla2019proxy01page3.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>lajolla2019proxy01page4.jpg
<TEXT>
Document 5 - file: lajolla2019proxy01page4.jpg

</DOCUMENT>
</SEC-DOCUMENT>